171 related articles for article (PubMed ID: 32049812)
1. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors.
Li D; Zhu R; Zhou L; Zhong D
Medicine (Baltimore); 2020 Feb; 99(7):e19090. PubMed ID: 32049812
[TBL] [Abstract][Full Text] [Related]
2. Phosphaturic mesenchymal tumor with an admixture of epithelial and mesenchymal elements in the jaws: clinicopathological and immunohistochemical analysis of 22 cases with literature review.
Wu H; Bui MM; Zhou L; Li D; Zhang H; Zhong D
Mod Pathol; 2019 Feb; 32(2):189-204. PubMed ID: 30206408
[TBL] [Abstract][Full Text] [Related]
3. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.
Folpe AL; Fanburg-Smith JC; Billings SD; Bisceglia M; Bertoni F; Cho JY; Econs MJ; Inwards CY; Jan de Beur SM; Mentzel T; Montgomery E; Michal M; Miettinen M; Mills SE; Reith JD; O'Connell JX; Rosenberg AE; Rubin BP; Sweet DE; Vinh TN; Wold LE; Wehrli BM; White KE; Zaino RJ; Weiss SW
Am J Surg Pathol; 2004 Jan; 28(1):1-30. PubMed ID: 14707860
[TBL] [Abstract][Full Text] [Related]
4. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and immunohistopathologic study of phosphaturic mesenchymal tumor].
Li DM; Wu HW; Li JD; Xia WB; Jiang Y; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):427-431. PubMed ID: 29886586
[No Abstract] [Full Text] [Related]
6. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical and molecular detection of the expression of FGF23 in phosphaturic mesenchymal tumors including the non-phosphaturic variant.
Shiba E; Matsuyama A; Shibuya R; Yabuki K; Harada H; Nakamoto M; Kasai T; Hisaoka M
Diagn Pathol; 2016 Mar; 11():26. PubMed ID: 26956379
[TBL] [Abstract][Full Text] [Related]
8. Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings.
Shustik DA; Ng DC; Sittampalam K
Int J Clin Exp Pathol; 2015; 8(6):7506-17. PubMed ID: 26261662
[TBL] [Abstract][Full Text] [Related]
9. CD56 may be a more useful immunohistochemical marker than somatostatin receptor 2A for the diagnosis of phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(7):8159-64. PubMed ID: 26339384
[TBL] [Abstract][Full Text] [Related]
10. ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.
Tajima S; Takashi Y; Ito N; Fukumoto S; Fukuyama M
Med Mol Morphol; 2016 Dec; 49(4):203-209. PubMed ID: 26122367
[TBL] [Abstract][Full Text] [Related]
11. Clinical, morphological and immunohistochemical analysis of 13 cases of phosphaturic mesenchymal tumor - A holistic diagnostic approach.
Chatterjee D; Bardia A; Pal R; Saikia UN; Bhadada SK; Radotra BD
Ann Diagn Pathol; 2021 Oct; 54():151783. PubMed ID: 34329884
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin.
Hautmann AH; Schroeder J; Wild P; Hautmann MG; Huber E; Hoffstetter P; Fleck M; Girlich C
Case Rep Endocrinol; 2014; 2014():729387. PubMed ID: 25221676
[TBL] [Abstract][Full Text] [Related]
13. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant.
Yamada Y; Kinoshita I; Kenichi K; Yamamoto H; Iwasaki T; Otsuka H; Yoshimoto M; Ishihara S; Toda Y; Kuma Y; Setsu N; Koga Y; Honda Y; Inoue T; Yanai H; Yamashita K; Ito I; Takahashi M; Ohga S; Furue M; Nakashima Y; Oda Y
Histopathology; 2018 Feb; 72(3):460-471. PubMed ID: 28858396
[TBL] [Abstract][Full Text] [Related]
14. Possibility of D2-40 as a diagnostic and tumor differentiation-suggestive marker for some of phosphaturic mesenchymal tumors.
Tajima S; Fukayama M
Int J Clin Exp Pathol; 2015; 8(8):9390-6. PubMed ID: 26464693
[TBL] [Abstract][Full Text] [Related]
15. [Ectopic hamartomatous thymoma: a clinicopathological and immunohistochemical study of two cases].
Wang J; Zhang RY
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):397-401. PubMed ID: 16251042
[TBL] [Abstract][Full Text] [Related]
16. Phosphaturic mesenchymal tumor, mixed connective tissue type, non-phosphaturic variant: report of a case and review of 32 cases from the Japanese published work.
Honda R; Kawabata Y; Ito S; Kikuchi F
J Dermatol; 2014 Sep; 41(9):845-9. PubMed ID: 25182295
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic vessels are present in phosphaturic mesenchymal tumours.
Williams K; Flanagan A; Folpe A; Thakker R; Athanasou NA
Virchows Arch; 2007 Nov; 451(5):871-5. PubMed ID: 17674036
[TBL] [Abstract][Full Text] [Related]
18. Intracranial phosphaturic mesenchymal tumors: report of 2 cases.
Mathis DA; Stehel EJ; Beshay JE; Mickey BE; Folpe AL; Raisanen J
J Neurosurg; 2013 Apr; 118(4):903-7. PubMed ID: 23350780
[TBL] [Abstract][Full Text] [Related]
19. The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma.
Li XM; Song X; Zhao XK; Hu SJ; Cheng R; Lv S; Du DF; Zhang XY; Lu JL; Ku JW; Zhang DY; Zhang Y; Fan ZM; Wang LD
BMC Cancer; 2018 Apr; 18(1):356. PubMed ID: 29609569
[TBL] [Abstract][Full Text] [Related]
20. Phosphaturic mesenchymal tumors. Survey of 8 cases from a single Mexican medical institution.
Angeles-Angeles A; Reza-Albarrán A; Chable-Montero F; Cordova-Ramón JC; Albores-Saavedra J; Martinez-Benitez B
Ann Diagn Pathol; 2015 Dec; 19(6):375-80. PubMed ID: 26386520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
